FDA-Approved Weight Loss in Orange County Soboba Clinic

Why Orange County Patients Are Choosing FDA-Approved Clinics Over Compounded Weight Loss Drugs
Understanding the FDA Crackdown on Compounded Weight Loss Medications

In early 2025, the FDA issued a decisive ruling banning compounded versions of popular GLP-1 weight loss drugs like Ozempic and Mounjaro. These alternatives, often distributed through online-only telehealth platforms, were found to lack proper regulation, consistent dosing, and clinical testing.